Yi Larson
Director/Board Member presso OLEMA PHARMACEUTICALS, INC.
Patrimonio netto: - $ in data 31/03/2024
Profilo
La signora Yi Larson è un amministratore indipendente di Olema Pharmaceuticals, Inc. Fa parte del Consiglio di amministrazione di Olema Pharmaceuticals, Inc. e Rayzebio, Inc. La signora Larson è stata precedentemente impiegata come direttore finanziario e vicepresidente esecutivo di Turning Point Therapeutics, Inc. Ha conseguito la laurea presso la Wharton School of the University of Pennsylvania, una laurea presso il Massachusetts Institute of Technology e un MBA presso la Wharton School of the University of Pennsylvania.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
LIANBIO
-.--% | 10/04/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
16/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Yi Larson
Società | Posizione | Inizio |
---|---|---|
OLEMA PHARMACEUTICALS, INC. | Director/Board Member | 06/04/2021 |
Precedenti posizioni note di Yi Larson
Società | Posizione | Fine |
---|---|---|
RAYZEBIO, INC. | Director/Board Member | 26/02/2024 |
LIANBIO | Director of Finance/CFO | 19/12/2023 |
TURG POIN | Director of Finance/CFO | 31/03/2021 |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Corporate Officer/Principal | - |
Formazione di Yi Larson
Massachusetts Institute of Technology | Graduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
OLEMA PHARMACEUTICALS, INC. | Health Technology |
RAYZEBIO, INC. | Health Technology |
Aziende private | 3 |
---|---|
Turning Point Therapeutics, Inc.
Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Finance |
LianBio |
- Borsa valori
- Insiders
- Yi Larson